DEA Questions CA’s Medical Marijuana Recommendation Requirements

Wooden blocks spelling “RESCHEDULING” arranged diagonally next to a gavel and two cannabis leaves on a green background, representing a potential DEA policy shift. Ca NORML

An order sent by the DEA to a California business says that patients who apply for a medical marijuana identification card in the state “are not required to obtain or provide a physician’s recommendation for marijuana,” and that this makes California businesses ineligible to receive DEA certification for their medical marijuana businesses under the new federal rescheduling order.

The order mentions the optional CDPH Form 9044, which a physician can sign saying “the use of medical marijuana is appropriate,” while verifying that the patient has a serious medical condition. The forms are being used by County Health Departments to issue state medical marijuana ID cards (which are also optional).

California voters legalized medical marijuana 30 years ago, with the passage of Proposition 215 in 1996. Prop. 215’s language requires a “written or oral recommendation or approval” from a physician in order for a patient to be exempt from certain state cannabis possession and cultivation laws. Possibly the law or regulations could be amended to require a written recommendation from a physician when applied to distribution by medical marijuana dispensaries / retailers. (Prop. 215 itself cannot be amended by the legislature, only by California voters.)

According to this post from Cal NORML boardmember and attorney Shay Gilmore, “The DEA cites the wrong provision for retail sales. Section 11362.715 governs county identification cards. Dispensary sales fall under DCC’s retail rule, Cal. Code Regs., tit. 4, § 15404(b), which requires a “valid physician’s recommendation.” But the DEA’s larger point stands. The California rule doesn’t require a recommendation to contain what federal (k)(5) lists, and the Compassionate Use Act allows recommendations to be oral under § 11362.5(d)….A cure would have to come from DCC, for example by requiring (k)(5)-style recommendations for medicinal sales, or from the Legislature, and nothing guarantees the DEA would accept either.”

Meanwhile, the DEA has requested that registrants submit a list of businesses participating in their approved supply chains by November 29, 2026. To help facilitate this process, all eligible medical cannabis licensees are encouraged to join the shared DEA Registration Information Form and Supply Chain Directory.

Cal NORML is in touch with attorneys on our legal committee, cannabis industry representatives and advocates, and has reached out to the CA Department of Cannabis Control to consider how CA businesses and patients might comply with DEA’s requirements.

Stay tuned to this page for updates. 

Stay Informed! Join California NORML’s Email Alert List